the Circle. · BILS 2027 · Berlin
The infrastructure that carries biology to scale.
10–11 February 2027 · Hotel Palace Berlin · Invited Audience
the Why
What scales. · What purifies. · Who manufactures the future.
01
Every biologics leader faces the same question. How does discovery become medicine at scale. The infrastructure between candidate and patient is being rebuilt.
02
Closed-door. By invitation. End-user led. A circle for the leaders building what comes next.
03
the Conversation. BILS is that room. Senior biologics leadership convened around the work that compounds. Upstream. Downstream. CDMO. Digital manufacturing and supply. Less noise. More signal.
04
Who attends. Senior faculty drawn from the leaders who own the plant, sign the batch and carry the accountability. Announced in cadence with the programme.
Thesis · The Room
Who manufactures
the future.
The gap.
Biology moves faster than the infrastructure designed to carry it. Process validation still needs a human signature. The recommendation behind it is now algorithmic. Viral safety clearance follows predictive models. Sterile filtration integrity is monitored by systems that outrun the operator. The compliance gap between model output and accountability has never been formally named.
The Conversation.
The corridor where biologics ambition becomes clinical supply · or breaks. The Conversation is where the leaders who carry the accountability meet before the inspection does.
The decision.
For the leaders who own the plant, sign the batch and are accountable for the intelligence layer no one has formally governed.
Uwe Gottschalk
Conference Chair · Operating Partner, Keensight Capital
The leaders.
Faculty announced in cadence with the programme.
the Circle. bils.ai · Invited to the Room
The room.
Up to
150
senior leaders
Ratio
80/20
end-user · partner
Format
Two
days
closed-door
Seniority
70%+
named principals
By invitation. By relevance. By room.
Invited · By Role
VP Bioprocess Development
Head of Downstream Processing
VP Quality & Compliance
SVP Digital Manufacturing
Head of Process Development
Director of Viral Safety
VP Manufacturing Operations
Head of CMC · Biologics
Chief Technical Officer
Invited · By Organisation
- Novo Nordisk · AstraZeneca · Roche · Sanofi
- Boehringer Ingelheim · GSK · MSD · Merck KGaA
- Pfizer · UCB · AbbVie · Novartis · Bayer · Amgen
- Lonza Biologics · Samsung Biologics · WuXi Biologics
- Fujifilm Diosynth · Rentschler · Charles River · Catalent
- Cytiva · Sartorius · Thermo Fisher Scientific · MilliporeSigma
BILS · The room. Over the years.
The forum, in frame.
BILS 2026
On stage.
BILS 2026
The conversation.
BILS 2026
In the room.
BILS 2026
In the room.
BILS 2026
For the patients.
Jesse McCool · CSO · Bionova Scientific
In the room. Berlin 2027.
BILS 2026
The interview.
BILS 2026
The room.
Partners · Who attends.
The organisations.
BILS 2027 · Berlin.
Who attends.
the Circle. bils.ai · Partner Positions
By request.
By invitation.
Partner packages and investment are shared directly.
Enter your access code to continue.
No access code? Request the prospectus →
Relationship · The Year
The year.
Not the forum. The relationship.
Q 1
The briefing.
Pre-forum strategic briefing. The room. The roster. The reason.
Q 2
The forum.
Q 3
The follow.
Named delegate follow-through. Curated meeting introductions.
Q 4
The intelligence.
Quarterly intelligence briefing from the Conversation Team.
A position. Not a placement.
the circle. · access
BILS 2027 · Request Access
The room
is taking
shape.
The prospectus is not public. Shared directly with the organisations that belong in the room.
Contact · For the Conversation